The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II study of tremelimumab and durvalumab with or without radiation for patients with relapsed small cell lung cancer (SCLC).
 
Taofeek Kunle Owonikoko
Stock and Other Ownership Interests - CAMBIUM MEDICAL TECHNOLOGIES
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; BerGenBio; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Eisai; EMD Serono; G1 Therapeutics; Lilly; Lilly; MedImmune; Novartis; PharmaMar; Sandoz; Seagen; Takeda
Speakers' Bureau - Abbvie
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Corvus Pharmaceuticals; G1 Therapeutics (Inst); Novartis (Inst); Regeneron (Inst); Stem CentRx (Inst); United Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - OVERCOMING ACQUIRED RESISTANCE TO CHEMOTHERAPY TREATMENTS THROUGH SUPPRESSION OF STAT3 (Inst); SELECTIVE CHEMOTHERAPY TREATMENTS AND DIAGNOSTIC METHODS RELATED THERETO (Inst)
Other Relationship - Roche/Genentech
 
Kristin Ann Higgins
Consulting or Advisory Role - AstraZeneca; Genentech; Varian Medical Systems
Speakers' Bureau - AstraZeneca
Research Funding - Reflexion Medical
 
Zhengjia Chen
No Relationships to Disclose
 
Chao Zhang
No Relationships to Disclose
 
Rathi Narayana Pillai
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Natera
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Clovis Oncology; Genentech/Roche; Novartis; Takeda
 
Conor Ernst Steuer
Honoraria - Merck
Consulting or Advisory Role - Abbvie; ARMO BioSciences; BerGenBio
Research Funding - Vaccinex
 
Nabil F. Saba
Honoraria - Bristol-Myers Squibb; Lilly; Merck; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merck; Pfizer
Research Funding - Bristol-Myers Squibb; Exelixis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; Merck; Pfizer
 
Suchita Pakkala
Consulting or Advisory Role - ARIAD
 
Dong Moon Shin
No Relationships to Disclose
 
Guojing Zhang
No Relationships to Disclose
 
Shuhua Wang
No Relationships to Disclose
 
Mohammed S Hossain
No Relationships to Disclose
 
Tyler Beardslee
No Relationships to Disclose
 
Anne Engelhart
No Relationships to Disclose
 
Janine Revenig
No Relationships to Disclose
 
Fadlo Khuri
No Relationships to Disclose
 
Walter John Curran, Jr.
Stock and Other Ownership Interests - Nanthealth
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb
Research Funding - Abbvie (Inst)
 
Sagar Lonial
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Juno Therapeutics; Merck; Novartis; Takeda
Research Funding - Bristol-Myers Squibb; Celgene; Takeda
 
Edmund K. Waller
No Relationships to Disclose
 
Suresh S. Ramalingam
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly/ImClone; Loxo; Merck; Nektar; Takeda; Tesaro
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Merck (Inst); Merck (Inst); Pfizer (Inst); Takeda (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - AstraZeneca